Download PDF
CC BY-NC-ND 4.0 · Horm Metab Res 2021; 53(08): 529-540
DOI: 10.1055/a-1510-8896
Endocrine Care

Hepatic-Metabolite-Based Intermittent Fasting Enables a Sustained Reduction in Insulin Resistance in Type 2 Diabetes and Metabolic Syndrome

Markus Rohner
1   EGB EpiGeneticBalance AG, Rheinfelden, Switzerland
,
Robert Heiz
2   Zentrum für Komplementärmedizin AG, Uster, Switzerland
,
Simon Feldhaus
3   Paramed AG, Haldenstrasse 1, Baar, Switzerland
,
Stefan R. Bornstein
4   Department of Medicine, Technische Universität Dresden, Dresden, Germany
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Insulin resistance is the hallmark of Type 2 Diabetes and is still an unmet medical need. Insulin resistance lies at the crossroads of non-alcoholic fatty liver disease, obesity, weight loss and exercise resistance, heart disease, stroke, depression, and brain health. Insulin resistance is purely nutrition related, with a typical molecular disease food intake pattern. The insulin resistant state is accessible by TyG as the appropriate surrogate marker, which is found to lead the personalized molecular hepatic nutrition system for highly efficient insulin resistance remission. Treating insulin resistance with a molecular nutrition-centered approach shifts the treatment paradigm of Type 2 Diabetes from management to cure. This allows remission within five months, with a high efficiency rate of 85%. With molecular intermittent fasting a very efficient treatment for prediabetes and metabolic syndrome is possible, improving the non-alcoholic fatty liver disease (NAFL) state and enabling the body to lose weight in a sustainable manner.

Key words

insulin resistance - diabetes remission - non-alcoholic fatty liver - weight loss resistance - epigenetics


Publication History

Received: 09 February 2021

Accepted after revision: 12 May 2021

Article published online:
30 June 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Madsen KS, Chi Y, Metzendorf MI. et al. Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus. Cochrane Database System Rev 2019; 1-122
    PubMedGoogle Scholar
  • 2 Ferrannini E, Gall W, Nannipieri M. et al. Identification of novel insulin resistance metabolites in a non-diabetic population by global biochemical profiling. Canad J Diabetes 2009; 33: 208
    CrossrefPubMedGoogle Scholar
  • 3 Nannini RD, Joyce BT, Zheng Y. et al. Epigenetic age acceleration and metabolic syndrome in the coronary artery risk development in young adults study. Clin Epigenet 2019; 160-169
    CrossrefPubMedGoogle Scholar
  • 4 De Rosa V, Galgani M, Santopaolo M. et al. Nutritional control of immunity: Balancing the metabolic requirements with an appropriate immune function. Semin Immunol 2015; 27: 300-309
    CrossrefPubMedGoogle Scholar
  • 5 Chavez-Reyes J, Escarcega-Gonzalez CE, Chavira-Suarez E. et al. Susceptibility for Some Infectious Diseases in Patients with Diabetes: The Key Role of Glycemia. Front Public Health 2021; 9: 559-595
    CrossrefPubMedGoogle Scholar
  • 6 Vestergaard Jensen A, Faurholt-Jepsen D, Banbaek Egelund G. et al. Undiagnosed Diabetes Mellitus in Community-Acquired Pneumonia: A Prospective Cohort Study. Clin Infect Dis 2017; 29: 2091-2098
    CrossrefPubMedGoogle Scholar
  • 7 Gardner JP, Li S, Srinavasan SR. et al. Rise in Insulin Resistance Is Associated with Escalated Telomere Attrition. Circulation 2005; 111: 2171-2177
    CrossrefPubMedGoogle Scholar
  • 8 Chen S, Chen Y, Liu X. et al. Association of Insulin Resistance with Chronic Kidney Disease in Non-Diabetic Subjects with Normal Weight. PLoS One 2013; 1-9
    PubMedGoogle Scholar
  • 9 Won Lee, Ha Park S. Association between depression and nonalcoholic fatty liver disease: Contributions of insulin resistance and inflammation. J Affect Disord 2021; 278: 259-263
    CrossrefPubMedGoogle Scholar
  • 10 Geraets AFJ, Köhler S, Muzambi R. et al. The association of hyperglycemia and insulin resistance with incident depressive symptoms over 4 years of follow-up: The Maastricht Study. Diabetologia 2020; 63: 2315-2328
    CrossrefPubMedGoogle Scholar
  • 11 Rundek T, Gardener H, Xu Q. et al. Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study. Arch Neurol 2010; 67: 1195-1200
    CrossrefPubMedGoogle Scholar
  • 12 Ford AH, Flicker L, Graeme GJ. et al. Insulin resistance and depressive symptoms in older men: the health in men study. Am J Geriatr Psychiatry 2015; 23: 872-880
    CrossrefPubMedGoogle Scholar
  • 13 Nägga K, Gustavsson AM, Stomrud E. et al. Increased midlife triglycerides predict brain β-amyloid and tau pathology 20 years later. Neurology 2018; 90: e73-e81
    CrossrefPubMedGoogle Scholar
  • 14 Sung H, Siegel RL, Rosenberg PS. et al. Emerging cancer trends among young adults in the USA: Analysis of a population-based cancer registry. Lancet 2019; 4: E137-E147
    PubMedGoogle Scholar
  • 15 Li X, Li G, Cheng T. et al. Association between triglyceride-glucose index and risk of incident diabetes: A secondary analysis based on a Chinese cohort study: TyG index and incident diabetes. Lipids Health Dis 2020; 8: 236
    CrossrefPubMedGoogle Scholar
  • 16 Ren H, Yang Y, Wang F. et al. Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19. Cardiovasc Diabetol 2020; 19: 58
    CrossrefPubMedGoogle Scholar
  • 17 Corona G, Pittocaro A, Vena W. et al. Diabetes is the most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis. Rev Endocr Metab Disord 2021; 1-22
    PubMedGoogle Scholar
  • 18 McGovern AP, Thomas NJ, Vollmer SJ. et al. The disproportionate excess mortality of COVID-19 in younger people with diabetes warrants vaccination prioritization. Diabetologia 2021; 64: 1184-1186
    CrossrefPubMedGoogle Scholar
  • 19 Kaiser A, Vollenweider P, Waeber G. et al. Prevalence, awareness and treatment of type 2 diabetes mellitus in Switzerland: the CoLaus study. Diabet Med 2012; 29: 190-197
    CrossrefPubMedGoogle Scholar
  • 20 Araujo J, Cai J, Stevens J. Prevalence of Optimal Metabolic Health in American Adults: National Health and Nutrition Examination Survey 2009–2016. Metab Syndr Relat Disord 2019; 17: 46-52
    CrossrefPubMedGoogle Scholar
  • 21 Kerr D, Miles P. Very low-calorie diets in diabetes: The Bournemouth experience. J Diabetes Nursing 2000; 4: 108-111
    PubMedGoogle Scholar
  • 22 Willi SM, Martin K, Datko FM. et al. Treatment of Type 2 Diabetes in Childhood Using a Very-Low-Calorie Diet. Diabetes Care 2004; 27: 348-353
    CrossrefPubMedGoogle Scholar
  • 23 Xin Y, Davies A, Briggs A. et al. Type 2 diabetes remission: 2-year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management program. Diabetologia 2020; 63: 2112-2122
    CrossrefPubMedGoogle Scholar
  • 24 Baskota A, Li S, Dhakal N. et al. Bariatric Surgery for Type 2 Diabetes Mellitus in Patients with BMI<30 kg/m2: A Systematic Review and Meta-Analysis. PLoS One 2015; 10: e0132335
    CrossrefPubMedGoogle Scholar
  • 25 Vistisen D, Witte DR, Tabak AG. et al. Patterns of Obesity Development before the Diagnosis of Type 2 Diabetes: The Whitehall II Cohort Study. PLoS Med 2014; 11: e1001602
    CrossrefPubMedGoogle Scholar
  • 26 Wu S, Fischer-Hoch SP, Reninger B. et al. Metabolic Health Has Greater Impact on Diabetes than Simple Overweight/Obesity in Mexican Americans. J Diabetes Res. 2016 Article ID 4094876
    PubMedGoogle Scholar
  • 27 Eckel N, Li Y, Kuxhaus O. et al. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses’ Health Study): 30-year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol 2018; 6: 714-724
    CrossrefPubMedGoogle Scholar
  • 28 Pietiläinen KH, Sysi-Aho M, Rissanen A. et al. Acquired obesity is associated with changes in the serum lipidomic profile independent pf genetic effects – a monozygotic twin study. PLoS One 2007; 2: e218
    CrossrefPubMedGoogle Scholar
  • 29 Owei I, Umekwe N, Provo C. et al. Insulin-sensitive and insulin-resistant obese and non-obese phenotypes: Role in the prediction of incident pre-diabetes in a longitudinal biracial cohort. BMJ Open Diabetes Res Care 2017; 5: e000415
    CrossrefPubMedGoogle Scholar
  • 30 Mongraw-Chaffin M, Foster MC, Anderson CAM. et al. Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol 2018; 71: 1857-1865
    CrossrefPubMedGoogle Scholar
  • 31 Bagnatti M, Ogunkolade W, Marshall C. et al. Glucolipotoxicity initiates pancreatic β-cell death through TNFR5/CD40-mediated STAT1 and NF-κB activation. Cell Death Disease 2016; 7: 2329
    CrossrefPubMedGoogle Scholar
  • 32 Telles S, Pal S, Sharma SK. et al. The association between the lipid profile and fasting blood glucose with weight-related outcomes in healthy obese adults. BMC Res Notes 2018; 11: 383
    CrossrefPubMedGoogle Scholar
  • 33 Lee J, Kim B, Kim W. et al. Lipid indices as simple and clinically useful surrogate markers for insulin resistance in the U.S. population. Sci Rep 2021; 11: 2366
    CrossrefPubMedGoogle Scholar
  • 34 Lim TK, Lee HS, Lee YJ. Triglyceride to HDL-cholesterol ratio and the incidence risk of type 2 diabetes in community-dwelling adults: A longitudinal 12-year analysis of the Korean Genome and Epidemiology Study. Diabetes Res Clin Pract 2020; 163: 108150
    CrossrefPubMedGoogle Scholar
  • 35 Rojas-Humpire R, Olarte-Durand M, Medina-Ramirez S. et al. Insulin Resistance Indexes as Biomarkers of Lifetime Cardiovascular Risk among Adults from Peru. J Nutr Metab 2021; 6633700: 1-8
    CrossrefPubMedGoogle Scholar
  • 36 Si Y, Fan W, Shan W. et al. Association between triglyceride glucose index and coronary artery disease with type 2 diabetes mellitus in middle-aged and elderly people. Medicine (Baltimore) 2021; 100: e25025
    CrossrefPubMedGoogle Scholar
  • 37 Arpon A, Milagro FI, Santos JL. et al. Interaction among sex, aging, and epigenetic process concerning visceral fat, insulin resistance, and dyslipidemia. Front Endocrinol 2019; 10: 496
    CrossrefPubMedGoogle Scholar
  • 38 Çin Aslan NN, Yardimci HH, Koç N. et al. Triglycerides/high-density lipoprotein cholesterol is a predictor similar to the triglyceride–glucose index for the diagnosis of metabolic syndrome using International Diabetes Federation criteria of insulin resistance in obese adolescents: a cross-sectional study. J Pediatr Endocrinol Metab 2020; 33: 777-784
    CrossrefPubMedGoogle Scholar
  • 39 Kron V, Verner M, Smetana P. et al. The Changes of Cholesterol Profile at the Different Insulin Resistance Range in the Czech Republic. Medicina (Kaunas) 2021; 57: 249
    CrossrefPubMedGoogle Scholar
  • 40 Lyu K, Zhang Y, Zhang D. et al. A Membrane-Bound Diacylglycerol Species Induces PKCε-Mediated Hepatic Insulin Resistance. Cell Metab 2020; 32: 654-664
    CrossrefPubMedGoogle Scholar
  • 41 Lee Y, Lai HTM, de Oliveira Otto MC. et al. Serial biomarkers of de novo lipogenesis fatty acids and incident heart failure in older adults: The Cardiovascular Health Study. J Am Heart Assoc 2020; 9: e014119
    CrossrefPubMedGoogle Scholar
  • 42 Rasmussen BB, Holmbäck UF, Volpi E. et al. Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle. J Clin Invest 2002; 110: 1687-1693
    CrossrefPubMedGoogle Scholar
  • 43 Imamura F, Fretts AM, Marklund M. et al. Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies. PLoS Med 2020; 17: e1003102
    CrossrefPubMedGoogle Scholar
  • 44 Kitae A, Hashimoto Y, Hamaguchi M. et al. The triglyceride and glucose index is a predictor of incident nonalcoholic fatty liver disease: A Population-Based Cohort Study. Can J Gastroenterol Hepatol 2019; 121574: 1-7
    PubMedGoogle Scholar
  • 45 Jimenez-Rivera C, Hadjiyannakis S, Davila J. et al. Prevalence and a risk factor for non-alcoholic fatty liver in children and youth with obesity. BMC Pediatrics 2017; 17: 113
    CrossrefPubMedGoogle Scholar
  • 46 Kolb H, Kempf K, Röhling M. et al. Insulin: too much of a good thing is bad. BMC Med 2020; 18: 224
    CrossrefPubMedGoogle Scholar
  • 47 Wadolowska L, Hamulka J, Kowalkowska J. et al. Skipping Breakfast and a Meal at School: Its Correlates in Adiposity Context. Report from the ABC of Healthy Eating Study of Polish Teenagers. Nutrients 2019; 11: 1563
    CrossrefPubMedGoogle Scholar
  • 48 Joo HJ, Kim GR, Park EC. et al. Association between Frequency of Breakfast Consumption and Insulin Resistance Using Triglyceride-Glucose Index: A Cross-Sectional Study of the Korea National Health and Nutrition Examination Survey (2016–2018). Int J Environ Res Public Health 2020; 17: 3322
    CrossrefPubMedGoogle Scholar
  • 49 Jakubowicz D, Landau S, Tsameret S. et al. Reduction in Glycated Hemoglobin and Daily Insulin Dose Alongside Circadian Clock Upregulation in Patients with Type 2 Diabetes Consuming a Three-Meal Diet: A Randomized Clinical Trial. Diabetes Care 2019; 42: 2171-2180
    CrossrefPubMedGoogle Scholar
  • 50 Breen C, Ryan M, McNulty B. et al. High saturated-fat and low-fiber intake: A comparative analysis of nutrient intake in individuals with and without type 2 diabetes. Nutr Diabetes 2014; 4: e104
    CrossrefPubMedGoogle Scholar
  • 51 Tiedemann LJ, Schmid SM, Hettel J. et al. Central insulin modulates food valuation via mesolimbic pathways. Nat Commun 2017; 8: 16052
    CrossrefPubMedGoogle Scholar
  • 52 Pugnaloni S, Alia S. Mancini et al. A Study on the Relationship between Type 2 Diabetes and Taste Function in Patients with Good Glycemic control. Nutrients 2020; 12: 1112-1122
    CrossrefPubMedGoogle Scholar
  • 53 Luukkonen PK, Sädevirta S, Zhou Y. et al. Saturated Fat Is More Metabolically Harmful to the Human Liver Than Unsaturated Fat or Simple Sugars. Diabetes Care 2018; 41: 1732-1739
    CrossrefPubMedGoogle Scholar
  • 54 Fryk E, Olausson J, Mossberg K. et al. Hyperinsulinemia and insulin resistance in the obese may develop as part of a homeostatic response to elevated free fatty acids: A mechanistic case-control and a population-based cohort study. Lancet 2021; 65: 103264
    PubMedGoogle Scholar
  • 55 Grubelnik V, Zmazek J. Markovič et al. Mitochondrial Dysfunction in Pancreatic Alpha and Beta-cells Associated with Type 2 Diabetes Mellitus. Life 2020; 10: 348
    CrossrefPubMedGoogle Scholar
  • 56 Hannon BA, Thompson SV, Edwards CG. et al. Dietary Fiber Is Independently Related to Blood Triglycerides Among Adults with Overweight and Obesity. Curr Dev Nutr 2018; 28: 094
    PubMedGoogle Scholar
  • 57 Dong Y, Chen L, Gutin B. et al. Total, Insoluble, and Soluble Dietary Fiber Intake and Insulin Resistance and Blood Pressure in Adolescents. Eur J Clin Nutr 2019; 73: 1172-1178
    CrossrefPubMedGoogle Scholar
  • 58 Gao X, Wang Y, Sun G. High dietary choline and betaine intake is associated with low insulin resistance in the Newfoundland population-. Nutrition 2017; 33: 28-34
    CrossrefPubMedGoogle Scholar
  • 59 Azemati B, Rajaram S, Jaceldo-Siegl K. et al. Animal-Protein Intake Is Associated with Insulin Resistance in Adventist Health Study 2 (AHS-2) Calibration Substudy Participants: A Cross-Sectional Analysis. Curr Dev Nutr 2017; 1: e000299
    CrossrefPubMedGoogle Scholar
  • 60 Meir AY, Rinott E, Tsaban G. et al. Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomized controlled trial. Gut. 2021: 1-11
    PubMedGoogle Scholar
  • 61 Castro-Barquero S, A Tresserra-Rimbau A, Vitelli-Storelli F. et al. Dietary Polyphenol Intake is Associated with HDL-Cholesterol and A Better Profile of Other Components of the Metabolic Syndrome: A PREDIMED-Plus Sub-Study. Nutrients 2020; 12: 689-696
    CrossrefPubMedGoogle Scholar
  • 62 McKaye J, Ho S, Jane M. et al. Overweight & obese Australian adults and micronutrient deficiency. BMC Nutr 2020; 1: 12
    CrossrefPubMedGoogle Scholar
  • 63 Hall E, Volkov P, Daveh T. et al. Effects of palmitate on genome-wide mRNA expression and DNA methylation patterns in human pancreatic islets. BMC Med 2014; 12: 103
    CrossrefPubMedGoogle Scholar
  • 64 Maples J, Brault JJ, Wiczak CA. et al. Differential epigenetic and transcriptional response of the skeletal muscle carnitine palmitoyltransferase 1B (CPT1B) gene to lipid exposure with obesity. Am J Physiol Endocrinol Metab 2015; 309: E345-E356
    CrossrefPubMedGoogle Scholar
  • 65 Bacha F, Klinepeter Bartz S, Puvau M. et al. Metabolic flexibility across the spectrum of glycemic regulation in youth. JCI Insight 2021; 6: e146000
    PubMedGoogle Scholar
  • 66 Irvin MR, Joehanes R, Mendelson M. et al. Epigenome-wide association study of fasting blood lipids in the Genetics of Lipid-lowering Drugs and Diet Network study. Circulation 2014; 130: 565-572
    CrossrefPubMedGoogle Scholar
  • 67 Mamtani M, Kulkarni H, Dyer TD. et al. Genome- and epigenome-wide association study of the hypertriglyceridemic waist in Mexican American families. Clin Epigenetics 2016; 6: 1-14
    PubMedGoogle Scholar
  • 68 Lai C, Parnell LD, Smith CE. et al. Carbohydrate and fat intake associated with risk of metabolic diseases through epigenetics of CPT1A. Am J Clin Nutr 2020; 112: 1200-1211
    CrossrefPubMedGoogle Scholar
  • 69 Arpón A, Milagro FI, Ramos-Lopez O. et al. Epigenome-wide association study in peripheral white blood cells involving insulin resistance. Sci Rep 2019; 9: 2445-2456
    CrossrefPubMedGoogle Scholar
  • 70 Rohner M. Method for evaluating foods, and nutritional systems for the prevention and treatment of chronic disease. European Patent EP3166639B1.
    PubMedGoogle Scholar
  • 71 Rohner M. Method for Weight Reduction. European Patent EP1962826B1.
    PubMedGoogle Scholar
  • 72 Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as a surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 2008; 6: 299-304
    CrossrefPubMedGoogle Scholar
  • 73 Masson W, Siniawski D, Lobo M. et al. Association between triglyceride/HDL cholesterol ratio and carotid atherosclerosis in postmenopausal middle-aged women. Endocrinol Nutr 2016; 63: 327-332
    CrossrefPubMedGoogle Scholar
  • 74 Bedogni G, Bellentani S, Miglioli L. et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006; 6: 33
    CrossrefPubMedGoogle Scholar
  • 75 Achilike I, Hazuda HP, Fowler SP. et al. Predicting the development of the metabolically healthy obese phenotype. Int J Obes 2015; 39: 228-234
    CrossrefPubMedGoogle Scholar
  • 76 Banks WA, Farr SA, Salameh TS. et al. Triglycerides cross the blood-brain barrier and induce central leptin and insulin receptor resistance. Int J Obes 2018; 42: 391-397
    CrossrefPubMedGoogle Scholar
  • 77 Kelly J, Karlsen M, Steinke G. Type 2 Diabetes Remission and Lifestyle Medicine: A Position Statement from the American College of Lifestyle Medicine.. Am J Lifestyle Med 2020; 14: 406-419
    CrossrefPubMedGoogle Scholar
  • 78 Ades PA, Savage PD, Marney AM. et al. Remission of recently diagnosed type 2 diabetes mellitus with weight loss and exercise. J Cardiopulm Rehabil Prev 2015; 35: 193-197
    CrossrefPubMedGoogle Scholar
  • 79 Ma M, Liu H, Yo J. et al. Triglyceride is independently correlated with insulin resistance and islet beta-cell function: a study in a population with different glucose and lipid metabolism states. Lipids Health Disease 2020; 19: 121-133
    CrossrefPubMedGoogle Scholar
  • 80 Lim EL, Hollingsworth KG, Aribisala MJ. et al. Reversal of type 2 diabetes: normalization of beta-cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 2011; 54: 2506-2514
    CrossrefPubMedGoogle Scholar
  • 81 Ye X, Kong W, Zafar MI. et al. Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. Cardiovasc Diabetol 2019; 18: 48-58
    CrossrefPubMedGoogle Scholar
  • 82 Halldin AK, Björkelund C. Cholesterol and triglyceride levels in midlife and risk of heart failure in women, a longitudinal study: the prospective population study of women in Gothenburg. BMJ Open 2020; 10: 1-8
    CrossrefPubMedGoogle Scholar
  • 83 Toth PP, Philip S, Hull M. et al. Association of Elevated Triglycerides with Increased Cardiovascular Risk and Direct Costs in Statin-Treated Patients. Mayo Clin Proc 2019; 94: 1670-1680
    CrossrefPubMedGoogle Scholar
  • 84 Shimoda M, Miyoshi-Takai M, Irie S. et al. Inadequate Triglyceride Management Worsens the Durability of Dipeptidyl Peptidase-4 Inhibitor in Subjects with Type 2 Diabetes Mellitus. J Diabetes Res 2017; 5856475: 1-8
    CrossrefPubMedGoogle Scholar
  • 85 Khan RS, Bril F, Cusi K. et al. Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease. Hepatology 2018; 70: 711-724
    CrossrefPubMedGoogle Scholar
  • 86 Farell A, Green H, Williams J. et al. Adapting medical weight loss strategies to NAFL – is it effective). AASLD 2019; 065
    PubMedGoogle Scholar
  • 87 Hydes TJ, Favi S, Loomba R. et al. Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFL and NASH. Clin Mol Hepatol 2020; 26: 383-400
    CrossrefPubMedGoogle Scholar